글로벌 척추이분증 치료 시장 - 2029년까지의 산업 동향 및 예측

척추이분증 치료 시장 분석 및 규모

척추이분증 치료 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 척추이분증은 일반적으로 척수 돌연변이의 결과로 발생하는 선천적 질환입니다. 이 질환은 남성보다 여성에게 더 많이 영향을 미칩니다. 비만, 당뇨병, 엽산 결핍과 같은 요인은 이 질환의 발병 위험 요인으로 간주됩니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 척추이분증 치료 시장의 성장률을 분석합니다. 글로벌 척추이분증 치료 시장의 예상 CAGR은 언급된 예측 기간 동안 약 8.40%인 경향이 있습니다. 시장은 2021년에 24억 2천만 달러로 평가되었으며 2029년까지 46억 1천만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

척추이분증 치료 시장 범위 및 세분화

Market Definition

Spina bifida is a kind of congenital defect affecting the spine and spinal cord and regularly appearing at birth. It is typically characterized by fragmented growth of the brain and spinal cord. This condition causes difficulties with bladder control and cognitive challenge. It can happen at any position along the spinal cord in case neural tube does not close properly. This causes defect in the formation and closure of backbone that protects the spinal cord. It often leads to damage of spinal cord and nerves associated with it.   

Global Spina Bifida Treatment Market Dynamics

Drivers

• Rising Awareness of the Disease

The increasing technological advancements is the primary factor driving the spina bifida treatment market. With the rising awareness about the disease, market players are bringing in much innovations due to technological advancements. For instance, in Nov 2015, B. Braun Melsungen AG announced the launch of Ster-ASSIST Sterile Peripheral IV Catheter Insertion Kit. In the same year, Medtronic acquired Twelve, Inc., a trans-catheter mitral valve replacement device developer.

• Increase in Elderly Population

As per the reports of the National Institute on Aging, around 524 million individuals, were above the age of 65 in the year 2010. This number is expected to rise and reach upto 1.5 billion, which is approximately 16% of the global population, by 2050. This boost the market growth.

Opportunities

• Increase in Spina Bifida

It has been witnessed that in the U.S, 1,500 to 2,000 of the more than 4 million babies born are affected by the condition each year. In the U.S., around 166,000 individuals are living with this condition. It is more common among the population with fair complexion. It is more commonly observed among women as compared to men.

• Increasing Demand for Retail Pharmacies

The rise in the number of spina bifida drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Development of Complications

There are sevral complications associated with the use of NGF and these could curb the growth of the global nerve growth factor (NGF) market  over a forecast period. Excessively high levels of NGF have also been linked to cancer tumor growth, asthma, and the worsening of acquired immunodeficiency syndrome (AIDS). All these factors restrict the growth of the market.

• High Cost

The huge expenditure associated with these agents hamper the market growth. The treatment involves different types of surgeries which demands high cost , thus, hindering the growth expansion.

This spina bifida treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the spina bifida treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Spina Bifida Treatment Market Scope

The spina bifida treatment market is segmented on the basis of type, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disorder

• Meningocele
• occulta
• Myelomeningocele
• Closed Neural Tube Defects

Type

• Spina Bifida Cystica
• Spina Bifida Occulta

Treatment

• Medicines
• Medical Procedure
• Urinary diversion
• Urinary catheterization
• Enema
• Surgeries
• Caesarean section
• Surgery of the spine
• Fetal endoscopic surgery
• Suprapubic cystostomy
• Spinal fusion
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Spina Bifida Treatment Market Regional Analysis/Insights

The spina bifida treatment market is analyzed and market size insights and trends are provided by type, treatment, distribution channel and end-user as referenced above.

The major countries covered in the spina bifida treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for spina bifida treatment market throughout the forecasted period due to the increase in research activities in this region and advanced healthcare facilities.

Asia-Pacific dominates the market due to the increasing awareness about the diseases and rapidly disposable income.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 글로벌 척추이분증 치료 시장 점유율 분석

척추이분증 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 척추이분증 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

척추이분증 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 파이저 주식회사(미국)
• Regeneron Pharmaceuticals Inc (미국)
• 아스텔라스파마 주식회사(일본)

• 머크 KGaA(독일)
• 사노피(프랑스)
• Bio-Rad Laboratories, Inc. (미국)
• 바이오케어 메디컬, LLC (미국)
• 릴리(미국)
• Teva Pharmaceutical Industries(이스라엘)
• B. Braun SE(독일)
• 카디널 헬스(미국)
• BD(미국)
• 보스턴 사이언티픽 코퍼레이션(미국)
• 홀로직 주식회사(미국)

SKU-54489